Search Results 551-560 of 15172 for alt

1. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 x ULN. Acute or chronic liver disease. Known hypersensitivity to inactive ingredients ...

2. Itraconazole Therapy In Bronchiectasis With Airway Mold - Mayo Clinic

   Participation eligibility · Known diagnosis of allergic bronchopulmonary aspergillosis or invasive fungal disease. · Abnormal baseline liver function tests (ALT, ...

3. Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) - Mayo Clinic

   ... (ALT, AST, and total bilirubin). Have ingested grapefruit juice or grapefruit products within a 7-day period before Day -1. Participating Mayo Clinic ...

4. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

   ... ALT ≤ 2.5 x ULN ; Alkaline phosphatase ≤2.5 x ULN; Negative Hepatitis B and Hepatitis C testing;; QTc interval ≤450ms. Exclusion Criteria: Radiation within ...

5. A Study of Intratumoral Injection of Autologous Dendritic Cells after High-Dose Conformal External Beam Radiotherapy in Patients with Unresectable Liver Cancer - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤5 x ULN;; Creatinine ≤2 mg/dL;; PT/INR ≤1.5 x ULN. Negative pregnancy test done ≤7 ...

6. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   AST and ALT ≤3 × upper limit of normal range (ULN);; Calculated creatinine clearance ≥30 mL/min using a modified Cockcroft-Gault calculation or a 24-hour ...

7. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL - Mayo Clinic

   Adequate liver function: total bilirubin <1.5x ULN, AST/ALT ≤ 3xULN Note: Patients with documented history of Gilbert's Syndrome and in whom total ...

8. Rheumatoid arthritis cohort biorepository - Clinical Trials

   Chronic active liver disease (AST>144 IU/L or ALT>165 IU/L); Oral warfarin group medications or history of blood clotting disorders; Pregnancy or ...

9. Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension - Mayo Clinic

   ALT > 3 times upper limit of normal (ULN) or AST >5 times ULN during screening; Estimated creatinine clearance <30 mL/min; Prior transjugular intrahepatic ...

10. A Study of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease - Mayo Clinic

    AST/ALT > 3 times ULN;; Hemoglobin < 10.0 g/dL;; Platelets < 75.0 x10^9/L;; Albuminemia < 3.0 g/dL. Suspected or documented infectious enterocolitis within two ...